» Articles » PMID: 30422241

Risk Factors, Patterns, and Outcomes of Late Recurrence After Liver Resection for Hepatocellular Carcinoma: A Multicenter Study From China

Overview
Journal JAMA Surg
Specialty General Surgery
Date 2018 Nov 14
PMID 30422241
Citations 221
Authors
Affiliations
Soon will be listed here.
Abstract

Importance: Late recurrence (more than 2 years) after liver resection for hepatocellular carcinoma (HCC) is generally considered as a multicentric tumor or a de novo cancer.

Objective: To investigate the risk factors, patterns, and outcomes of late recurrence after curative liver resection for HCC.

Design, Setting, And Participants: This study was a multicenter retrospective analysis of patients who underwent curative liver resection for HCC at 6 hospitals in China from January 2001 to December 2015. Among 734 patients who were alive and free of recurrence at 2 years after resection, 303 patients developed late recurrence. Data were analyzed from June 2017 to February 2018.

Interventions: Liver resection for HCC.

Main Outcomes And Measures: Risk factors of late recurrence as well as patterns, treatments, and long-term outcomes of patients with late recurrence. Univariate and multivariate Cox regression analyses were performed to identify independent risk factors of late recurrence.

Results: Of the included 734 patients, 652 (88.8%) were male, and the mean (SD) age was 51.0 (10.3) years. At a median (interquartile range) follow-up of 78.0 (52.8-112.5) months, 303 patients (41.3%) developed late recurrence. Multivariate analysis revealed that male sex, cirrhosis, multiple tumors, satellite nodules, tumor size greater than 5 cm, and macroscopic and microscopic vascular invasion were independent risk factors of late recurrence. Of the 303 patients with late recurrence, 273 (90.1%) had only intrahepatic recurrence, 30 (9.9%) had both intrahepatic and extrahepatic recurrence, and none had only extrahepatic recurrence. Potentially curative treatments were given to 165 of 303 patients (54.5%) with late recurrence, which included reresection, transplant, and local ablation. Multivariate Cox regression analysis showed that regular surveillance for postoperative recurrence (hazard ratio [HR], 0.470; 95% CI, 0.310-0.713; P = .001), cirrhosis (HR, 1.381; 95% CI, 1.049-1.854; P = .02), portal hypertension (HR, 2.424; 95% CI, 1.644-3.574; P < .001), Child-Pugh grade of B or C (HR, 1.376; 95% CI, 1.153-1.674; P < .001), Barcelona Clinic Liver Cancer stage B (HR, 1.304; 95% CI, 1.007-1.708; P = .04) and stage C (HR, 2.037; 95% CI, 1.583-2.842; P < .001), and potentially curative treatment (HR, 0.443; 95% CI, 0.297-0.661; P < .001) were independent predictors of overall survival for patients with late recurrence.

Conclusions And Relevance: Late recurrence after HCC resection was associated with sex, cirrhosis, and several aggressive tumor characteristics of the initial HCC. The patterns of late recurrence suggested surveillance for recurrence after 2 years of surgery should be targeted to the liver. Postoperative surveillance improved the chance of potentially curative treatments, with improved survival outcomes in patients with late recurrence.

Citing Articles

Spatial immune scoring system predicts hepatocellular carcinoma recurrence.

Jia G, He P, Dai T, Goh D, Wang J, Sun M Nature. 2025; .

PMID: 40074893 DOI: 10.1038/s41586-025-08668-x.


Patterns and outcomes of early and late recurrence after hepatectomy for hepatocellular carcinoma with microvascular invasion: a multicenter study in China.

Zhang X, Zhang T, Wu F, Li Z, Xiao Z, Yu Z Hepatol Int. 2025; .

PMID: 40063322 DOI: 10.1007/s12072-025-10802-w.


Enhanced prediction of 5-year postoperative recurrence in hepatocellular carcinoma by incorporating LASSO regression and random forest models.

Su B, Zhu C, Cao J, Peng R, Tu D, Jiang G Surg Endosc. 2025; .

PMID: 40032663 DOI: 10.1007/s00464-025-11631-6.


Radiofrequency ablation for peribiliary hepatocellular carcinoma: propensity score matching analysis.

Cui J, Sui X, Liu K, Huang M, Zheng Y, Zhao X Insights Imaging. 2025; 16(1):45.

PMID: 39971810 PMC: 11839967. DOI: 10.1186/s13244-025-01919-5.


Radiofrequency ablation of hepatocellular carcinoma: Current status, challenges, and prospects.

Wang H, Wu Z, Cui D, Shi Y, Zhai B Liver Res. 2025; 7(2):108-115.

PMID: 39958948 PMC: 11791925. DOI: 10.1016/j.livres.2023.05.002.


References
1.
Zhou Y, Yang J, Li B, Yin Z, Xu F, Wang B . Risk factors for early recurrence of small hepatocellular carcinoma after curative resection. Hepatobiliary Pancreat Dis Int. 2010; 9(1):33-7. View

2.
Pecchi A, Besutti G, De Santis M, Del Giovane C, Nosseir S, Tarantino G . Post-transplantation hepatocellular carcinoma recurrence: Patterns and relation between vascularity and differentiation degree. World J Hepatol. 2015; 7(2):276-84. PMC: 4342610. DOI: 10.4254/wjh.v7.i2.276. View

3.
Zheng J, Chou J, Gonen M, Vachharajani N, Chapman W, Doyle M . Prediction of Hepatocellular Carcinoma Recurrence Beyond Milan Criteria After Resection: Validation of a Clinical Risk Score in an International Cohort. Ann Surg. 2017; 266(4):693-701. PMC: 8404085. DOI: 10.1097/SLA.0000000000002360. View

4.
Zhang X, Li C, Wen T, Yan L, Li B, Yang J . Appropriate treatment strategies for intrahepatic recurrence after curative resection of hepatocellular carcinoma initially within the Milan criteria: according to the recurrence pattern. Eur J Gastroenterol Hepatol. 2015; 27(8):933-40. DOI: 10.1097/MEG.0000000000000383. View

5.
Montasser M, Shaker M, Albreedy A, Montasser I, El Dorry A . Risk factors for early intrahepatic distant recurrence after radiofrequency ablation for hepatocellular carcinoma in Egyptian patients. J Dig Dis. 2014; 15(12):676-83. DOI: 10.1111/1751-2980.12190. View